Environment
No direct effect
Neutral — no direct effect identified.
Benefits
- No material direct effect identified.
Risks
- No material direct effect identified.
StateIndianaIntroduced
SB 91: Syringe exchange program.
Michael Crider
SB 91 status: Introduced — Public Law 144 (updated Mar 10, 2026).
Source
OpenStates
Confidence
Low
Analysis basis
OpenStates summary
01
What this bill does
Official summary alongside an AI-generated read on where it stands and why.
Overall Score
53OUT OF 100
Score:53/100 civic fit
Risk:Moderate Risk
Impact:Moderate Impact 60/100
Constitutionality85%
Bipartisan70%
Public opinion50%
Bill summary
Prohibits a qualified entity that operates a syringe exchange program (program) from establishing or operating a fixed site for the distribution or exchange of a syringe or needle within 1,000 feet of specified facilities. Creates an exception. Allows the Indiana department of health to deny, suspend, or revoke a qualified entity's annual registration for a violation. Amends the duties of a qualified entity that operates a program. Establishes requirements for program participation. Prohibits a qualified entity that operates a program from providing chemical reagents or precursors. Requires the state health commissioner to investigate any complaint regarding a qualified entity's noncompliance with the qualified entity's duties concerning the operation of a program. Permits the state health commissioner to suspend or terminate the approval of a qualified entity for noncompliance. Extends the expiration of the program to July 1, 2031.
02
Impact analysis
✦ AI analysisModeled effects across six domains, estimated from bill text and comparable legislation.
Economy
No direct effect
Neutral — no direct effect identified.
Benefits
- No material direct effect identified.
Risks
- No material direct effect identified.
Society
Mixed / Neutral
45%
Benefits
- Ensures program continuity until July 1, 2031
- Standardizes operational requirements for entities
- Maintains access to syringe exchange services
Risks
- Distance buffers may displace services from high-need areas
- Prohibitions on chemical reagents limit harm reduction scope
- Stringent registration requirements may deter providers
Technology Industry
No direct effect
Neutral — no direct effect identified.
Benefits
- No material direct effect identified.
Risks
- No material direct effect identified.
Civic Accountability
Positive outlook
60%
Benefits
- Strengthens oversight of registered syringe exchange programs
- Establishes a formal complaint investigation process
- Clarifies IDOH authority to suspend or revoke approval
Risks
- Centralizes enforcement power within IDOH
- Potential for arbitrary enforcement of buffer zones
- Limited reporting requirements for investigation outcomes
Public Health & Safety
Mixed / Neutral
55%
Benefits
- Extends the life of state-authorized harm reduction
- Ensures standardized compliance across all sites
- Formalizes health-based complaint reviews
Risks
- Distance restrictions may create service deserts
- Prohibits essential auxiliary harm reduction tools
- Regulatory burden may lead to service shutdowns
03
How trustworthy & consequential it is
Sourcing already shown above, this is what the analysis found worth flagging.
Source
OpenStates
Official bill text or data from OpenStates.
Confidence
Low
Information is limited or incomplete.
Analysis basis
OpenStates summary
Source used for this bill's analysis.
Source note
LegiScan returned a PDF-only document. PDF extraction is not enabled in this build, so the pipeline used a safer fallback.
Analysis scope
Analysis based on abstract metadata; full statutory language not reviewed.
04
Where it stands
Official record- IntroducedCurrent
- CommitteeUpcoming
- Chamber votesUpcoming
- Final agreementUpcoming
- GovernorUpcoming
- EnactedUpcoming
05
How it affects your district
✦ Personalized
Set your location
Add your district to see how this bill may affect your community and who to contact.
Your Representatives
Your representatives appear here once you add your location.
06
Take action
Contact your representatives
Let them know how you feel about this bill.
Share your view
Join the discussion and see what others are saying.
Track this bill
Stay updated on progress and changes.